UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049915
Receipt number R000056853
Scientific Title An exploratory prospective study of the relationship between duodenal cancer and Lynch syndrome
Date of disclosure of the study information 2023/01/01
Last modified on 2023/08/07 13:58:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory prospective study of the relationship between duodenal cancer and Lynch syndrome

Acronym

An exploratory prospective study of the relationship between duodenal cancer and Lynch syndrome

Scientific Title

An exploratory prospective study of the relationship between duodenal cancer and Lynch syndrome

Scientific Title:Acronym

An exploratory prospective study of the relationship between duodenal cancer and Lynch syndrome

Region

Japan


Condition

Condition

duodenal cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To investigate how many patients with duodenal cancer are included in the Lynch syndrome

Basic objectives2

Others

Basic objectives -Others

Patients with duodenal cancer as a result of endoscopic treatment will be examined for microsatellite instability and mismatch repair gene mutations.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Rates of Lynch Syndrome in patients with duodenal cancer

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with duodenal cancer after endoscopic resection, 20 years of age or older

Key exclusion criteria

Cases in which the subject is incapable of consenting due to dementia, etc.
Cases in which the subject refuses to participate in the study after enrollment
Other cases that the doctor judges that the subject is not suitable for enrollment

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Motohiko
Middle name
Last name Kato

Organization

Keio University School of Medicine

Division name

Division of Research and Development for Minimally Invasive Treatment, Cancer Center

Zip code

1608582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-1211

Email

motohikokato@keio.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Minezaki

Organization

Keio University School of Medicine

Division name

Division of Research and Development for Minimally Invasive Treatment, Cancer Center

Zip code

1608582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-1211

Homepage URL


Email

d-mine@keio.jp


Sponsor or person

Institute

Keio University

Institute

Department

Personal name



Funding Source

Organization

Keio University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School if Medicine

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

Tel

03-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 12 Month 27 Day

Date of IRB

2023 Year 01 Month 01 Day

Anticipated trial start date

2023 Year 01 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To observe whether patients with duodenal cancer as a result of endoscopic treatment are diagnosed with Lynch Syndrome at subsequent additional examinations.


Management information

Registered date

2022 Year 12 Month 27 Day

Last modified on

2023 Year 08 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056853


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name